ArticleBMJ open2024

Cardiovascular safety of evogliptin dual and triple therapy in patients with type 2 diabetes: a nationwide cohort study.

Sohee Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.